News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health Perspectives
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pain
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
Predictions for 2026: Our January 2026 issue|
MHE State of the Industry survey|
ASH 2025|
AMCP Nexus 2025|
2025 Fall Clinical Dermatology|
ASRS 2025
Advertisement

Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Advertisement

Articles by Thomas Nusbickel, Chief Commercial Officer, Celltrion USA

Celltrion USA is Committed to Delivering Advancements in IBD Treatments

ByThomas Nusbickel, Chief Commercial Officer, Celltrion USA
November 6th 2023
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Managed Healthcare Executive

    1

    Nearly all Ryan White HIV/AIDS Program patients virally suppressed in 2024

    2

    Predictions about AI in 2026 from Chris Louma, Courtney Bragg, MBA, Katerina Guerraz, M.P.H., and others

    3

    Telehealth is now a long-term part of Medicare mental health care

    4

    Risk-based breast cancer screening reliable, preferred by women over annual screening, study shows

    5

    Detalimogene gene therapy shows promising results in bladder cancer trial

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Formulary Watch
    • Pharmacy Benefit Management Institute
    Managed Healthcare Executive
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us